4827-06-9

81820-08-8 N-[4-(2-{(2E)-2-[5-methyl-2-oxo-1-(piperidin-1-ylmethyl)-1,2-dihydro-3H-indol-3-ylidene]hydrazinyl}-2-oxoethoxy)phenyl]acetamide

4827-06-9 4-Pyridazinol, 3,6-diphenyl-

60050-22-8 Bicyclo[3.2.0]heptane-1-carbonitrile, 2,6-dimethyl-7-oxo-

16014-65-6 3-amino-5-(trifluoromethyl)-2-Pyrazinecarboxylic acid

160292-86-4 4-Cinnolinecarboxylic acid, 3-amino-7-(trifluoromethyl)-, 1-oxide

4826-93-1 3(2H)-Pyridazinone, 6-(2,5-dimethylphenyl)-

872851-24-6 1-Naphthalenesulfonic acid, 4-amino-, manganese(2+) salt (2:1)

656231-62-8 Ethanone, 1-[2-hydroxy-1-(phenylmethyl)cyclohexyl]-

417706-63-9 Benzenamine, 2,6-dinitro-N-(tri-1-pyrrolidinylphosphoranylidene)-

874789-43-2 Bicyclo[2.2.2]octane-2-carboxylic acid,4,6,6-trimethyl-8-(1-methylethenyl)-5-oxo-, (1S,2S,4S,8S)-

637338-10-4 4H-1,4-Benzodiazepine-4,8-dicarboxylic acid,1,2,3,5-tetrahydro-2-oxo-, 4-(1,1-dimethylethyl) 8-methyl ester

167954-35-0 1-Pyrrolidinecarboxamide,2-[[bis[4-(dimethylamino)phenyl]phosphino]methyl]-N,N-dimethyl-, (S)-

165803-63-4 3-(4-bromophenyl)propyl methanesulphonate

817599-79-4 Benzothiazole, 2-[(ethenyloxy)[4-(trifluoromethyl)phenyl]methyl]-

4827-17-7 TMB Stable Liquid Substrate 1.25mM/Liter for HRPO (3,3'',5,5''-Tetramethylbenzidine)

640761-75-7 Urea, N-[2-(phenylmethyl)phenyl]-N'-2-thiazolyl-

167954-19-0 1H-Indol-3-amine, N-(4-nitrophenyl)-

82040-81-1 2,6-dibromo-4-(2-nitroprop-1-en-1-yl)phenol

81820-14-6 N-(4-{2-[(2E)-2-{5-chloro-1-[(4-methylpiperazin-1-yl)methyl]-2-oxo-1,2-dihydro-3H-indol-3-ylidene}hydrazinyl]-2-oxoethoxy}phenyl)acetamide

5330-87-0 2-({5-[(4-methoxyphenoxy)methyl]-4-prop-2-en-1-yl-4H-1,2,4-triazol-3-yl}sulfanyl)-N-[3-(methylsulfanyl)phenyl]acetamide